• 1
    Kunisaki C, Akiyama H, Nomura M, et al. Clinicopathologic characteristics and surgical outcomes of mucinous gastric carcinoma. Ann Surg Oncol. 2006; 13: 836-842.
  • 2
    HamiltonSR, AaltonenLA, eds. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Digestive System. Lyon, France: IARC Press; 2001.
  • 3
    Kawamura H, Kondo Y, Osawa S, et al. A clinicopathologic study of mucinous adenocarcinoma of the stomach. Gastric Cancer. 2001; 4: 83-86.
  • 4
    Yasuda K, Adachi Y, Shiraishi N, Yamaguchi K, Shiromizu A, Kitano S. Pathology and prognosis of mucinous gastric carcinoma. J Surg Oncol. 2001; 76: 272-277.
  • 5
    Adsay NV. Role of MUC genes and mucins in pancreatic neoplasia. Am J Gastroenterol. 2006; 101: 2330-2332.
    Direct Link:
  • 6
    Pinto-de-Sousa J, Reis CA, David L, Pimenta A, Cardoso-de-Oliveira M. MUC5B expression in gastric carcinoma: relationship with clinicopathological parameters and with expression of mucins MUC1, MUC2, MUC5AC and MUC6. Virchows Arch. 2004; 444: 224-230.
  • 7
    Ogino S, Brahmandam M, Cantor M, et al. Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component. Mod Pathol. 2006; 19: 59-68.
  • 8
    Kim MA, Lee HS, Lee HE, Jeon YK, Yang HK, Kim WH. EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number. Histopathology. 2008; 52: 738-746.
  • 9
    Boland CR, Thibodeau SN, Hamilton SR, et al. A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res. 1998; 58: 5248-5257.
  • 10
    Kang GH, Yoon GS, Lee HK, Kwon YM, Ro JY. Clinicopathologic characteristics of replication error-positive gastric carcinoma. Mod Pathol. 1999; 12: 15-20.
  • 11
    Kimura M, Tsuda H, Morita D, et al. A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurements. Virchows Arch. 2004; 445: 255-262.
  • 12
    Tajima Y, Shimoda T, Nakanishi Y, et al. Gastric and intestinal phenotypic marker expression in gastric carcinomas and its prognostic significance: immunohistochemical analysis of 136 lesions. Oncology. 2001; 61: 212-220.
  • 13
    Hidaka S, Tanaka K, Takeshita H, et al. Clinicopathology and prognosis of mucinous gastric carcinoma. Hepatogastroenterology. 2008; 55: 791-794.
  • 14
    Perez RO, Bresciani BH, Bresciani C, et al. Mucinous colorectal adenocarcinoma: influence of mucin expression (Muc1, 2 and 5) on clinicopathological features and prognosis. Int J Colorectal Dis. 2008; 23: 57-65.
  • 15
    Papadopoulos VN, Michalopoulos A, Netta S, et al. Prognostic significance of mucinous component in colorectal carcinoma. Tech Coloproctol. 2004; 8( suppl 1): s123-s125.
  • 16
    Wu CY, Yeh HZ, Shih RTP, Chen GH. A clinicopathologic study of mucinous gastric carcinoma including multivariate analysis. Cancer. 1998; 83: 1312-1318.
  • 17
    Woo LS, Kim DY, Kim YJ, Kim SK. Clinicopathologic features of mucinous gastric carcinoma. Dig Surg. 2002; 19: 286-290.
  • 18
    Baldus S, Zirbes TK, Engel S, et al. Correlation of the immunohistochemical reactivity of mucin peptide cores MUC1 and MUC2 with the histopathological subtype and prognosis of gastric carcinomas. Int J Cancer. 1998; 79: 133-138.
  • 19
    Gurbuz Y, Kahlke V, Kloppel G. How do gastric carcinoma classification system relate to mucin expression patterns? An immunohistochemical analysis in a series of advanced gastric carcinomas. Virchows Arch. 2002; 440: 505-511.
  • 20
    Wirtz HC, Muller W, Noguchi T, et al. Prognostic value and clinicopathological profile of microsatellite instability in gastric cancer. Clin Cancer Res. 1998; 4: 1749-1754.
  • 21
    Lee HS, Choi SI, Lee HK, et al. Distinct clinical features and outcomes of gastric cancers with microsatellite instability. Mod Pathol. 2002; 15: 632-640.
  • 22
    Hayden JD, Cawkwell L, Quirke P, et al. Prognostic significance of microsatellite instability in patients with gastric carcinoma. Eur J Cancer. 1997; 33: 2342-2346.
  • 23
    Falchetti M, Calogero S, Lupi R, et al. Gastric cancer with high-level microsatellite instability: target gene mutations, clinicopathologic features, and long-term survival. Hum Pathol. 2008; 39: 925-932.
  • 24
    Park SY, Lee HS, Choe G, Chung JH, Kim WH. Clinicopathological characteristics, microsatellite instability, and expression of mucin core proteins and p53 in colorectal mucinous adenocarcinomas in relation to location. Virchows Arch. 2006; 449: 40-47.
  • 25
    Luttges J, Beyser K, Pust S, Paulus AN, Ruschoff J, Kloppel G. Pancreatic mucinous noncystic (colloid) carcinomas and intraductal papillary mucinous carcinomas are usually microsatellite stable. Mod Pathol. 2003; 16: 537-542.